Literature DB >> 32181443

Effects of Preinjury and Postinjury Exposure to Caffeine in a Rat Model of Traumatic Brain Injury.

Theresa A Lusardi1,2, Nikki K Lytle2,3, Hoda M Gebril4, Detlev Boison4.   

Abstract

Background: Lethal apnea is a significant cause of acute mortality following a severe traumatic brain injury (TBI). TBI is associated with a surge of adenosine, which also suppresses respiratory function in the brainstem. Methods and Materials: This study examined the acute and chronic effects of caffeine, an adenosine receptor antagonist, on acute mortality and morbidity after fluid percussion injury.
Results: We demonstrate that, regardless of preinjury caffeine exposure, an acute bolus of caffeine given immediately following the injury dosedependently prevented lethal apnea and has no detrimental effects on motor performance following sublethal injuries. Finally, we demonstrate that chronic caffeine treatment after injury, but not caffeine withdrawal, impairs recovery of motor function. Conclusions: Preexposure of the injured brain to caffeine does not have a major impact on acute and delayed outcome parameters; more importantly, a single acute dose of caffeine after the injury can prevent lethal apnea regardless of chronic caffeine preexposure. Copyright 2020, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  adenosine; apnea; caffeine; fluid percussion injury; rat; traumatic brain injury

Year:  2020        PMID: 32181443      PMCID: PMC7071069          DOI: 10.1089/caff.2019.0012

Source DB:  PubMed          Journal:  J Caffeine Adenosine Res        ISSN: 2573-3397


  71 in total

Review 1.  Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

Authors:  B B Fredholm; K Bättig; J Holmén; A Nehlig; E E Zvartau
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

2.  Adenosine A2A receptors are expressed by GABAergic neurons of medulla oblongata in developing rat.

Authors:  Syed I A Zaidi; Anjum Jafri; R J Martin; Musa A Haxhiu
Journal:  Brain Res       Date:  2006-01-17       Impact factor: 3.252

Review 3.  Adenosine and neuroprotection.

Authors:  B B Fredholm
Journal:  Int Rev Neurobiol       Date:  1997       Impact factor: 3.230

4.  A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment.

Authors:  B Johansson; V Georgiev; K Lindström; B B Fredholm
Journal:  Brain Res       Date:  1997-07-11       Impact factor: 3.252

Review 5.  Prehospital intubation of brain-injured patients.

Authors:  Daniel P Davis
Journal:  Curr Opin Crit Care       Date:  2008-04       Impact factor: 3.687

Review 6.  Recovery of respiratory activity after C2 hemisection (C2HS): involvement of adenosinergic mechanisms.

Authors:  Kwaku D Nantwi
Journal:  Respir Physiol Neurobiol       Date:  2009-08-03       Impact factor: 1.931

7.  Seizure suppression by adenosine-releasing cells is independent of seizure frequency.

Authors:  Detlev Boison; Alexander Huber; Vivianne Padrun; Nicole Déglon; Patrick Aebischer; Hanns Möhler
Journal:  Epilepsia       Date:  2002-08       Impact factor: 5.864

8.  Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain.

Authors:  D Shi; O Nikodijević; K A Jacobson; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

9.  Control and function of the homeostatic sleep response by adenosine A1 receptors.

Authors:  Theresa E Bjorness; Christine L Kelly; Tianshu Gao; Virginia Poffenberger; Robert W Greene
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

10.  Rhythm generation by the pre-Bötzinger complex in medullary slice and island preparations: effects of adenosine A(1) receptor activation.

Authors:  Richard J Vandam; Edward J Shields; Jonathan D Kelty
Journal:  BMC Neurosci       Date:  2008-10-01       Impact factor: 3.288

View more
  1 in total

1.  Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury.

Authors:  Susan A Farr; Salvatore Cuzzocrea; Emanuela Esposito; Michela Campolo; Michael L Niehoff; Timothy M Doyle; Daniela Salvemini
Journal:  J Neuroinflammation       Date:  2020-11-12       Impact factor: 8.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.